Delivery Order SPE2DR25D1017-SPE2DR26F9BFZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,176.37 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 3, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order valued at $4,152.50 to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is set to be completed by December 5, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical distribution...
- The Defense Logistics Agency awarded a $21,479.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. This is a non-set-aside competitive award with an ultimate completion date of November 5, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be performed from the contractor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $27,169.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on November 24, 2025, with completion targeted for November 25, 2025. This firm fixed price, non-set-aside delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $10,623.31 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors, with a ceiling value of $1,554.67 and an ultimate completion date of November 10, 2025. This is a firm fixed-price, non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be...
- The Defense Logistics Agency awarded a $18,908.20 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. As a pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $6,948.71 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 5, 2025. This non-competitive, firm fixed-price delivery order was issued on November 4, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA's Medical...
- The Defense Logistics Agency awarded a $5,434.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside competitive award will be fulfilled from the vendor's place of business in Conshohocken, Pennsylvania, with an ultimate completion date of November 25, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BFZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors, valued at $5,857.21. This firm fixed-price delivery order is not set-aside and represents a competitively awarded transaction under the company's existing contract vehicle with DLA. The ultimate completion date is December 12, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a prime vendor agreement valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen supplies a comprehensive range of medications and medical devices to support military and veteran healthcare systems. The Repatha product supplied under this order is a cardiovascular medication used for cholesterol management, consistent with AmerisourceBergen's portfolio of specialty medications delivered across multiple therapeutic domains to Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 12/10/25 |